The Danish parliament is currently debating a bill about a new experiment with risk sharing regarding reimbursement of medicine. In the pilot scheme, the state will reimburse the drug if medical companies take the responsibility that the medicine is only used in the prescribed manner.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.